PD‐L1 expression refers to the membrane expression of PD‐L1 by tumor cells, which was presumed to be a predictive biomarker for the patient response early in the use of anti‐PD‐(L)1 agents, which has been proven by several clinical trials.2, 18, 19, 20. The gene discussed is CD274; the disease is neoplasm.